window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

AI in Pharma

  • Biologics & Biosimilars,Drug Development,Oncology,Research & Development,Technology and platforms

    PhoreMost unveils breakthrough platform to rationalise molecular glue drug discovery

    High-throughput GlueSEEKER platform expands druggable space by identifying novel induced [...]

    July 22, 2025
  • Artificial Intelligence,Drug Development,Market Access & Commercialization,Partnerships & Funding

    Optibrium secures multi-million-pound funding to power global AI drug discovery expansion

    Backing from Shawbrook follows rapid customer growth and positions Optibrium [...]

    July 8, 2025
  • Artificial Intelligence,Clinical Development,Drug Development,Regulatory Affairs,Technology and platforms

    Why generic AI fails pharma and how purpose-built AI is revolutionizing drug development

    Artificial intelligence (AI) is transforming many industries, but in pharma, [...]

    July 3, 2025
  • Artificial Intelligence,Market Access & Commercialization,Regulatory Affairs,Supply Chain & Logistics,Technology and platforms

    From tariffs to AI: Why pharma procurement needs a rethink

    As global trade policies shift and compliance pressures mount, pharma [...]

    July 7, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Clinical Trials,Regulatory Affairs

    FDA shifts drug testing paradigm with plan to replace animal studies in monoclonal antibody development

    Regulators back AI and organ-on-a-chip technologies to modernize safety evaluation [...]

    June 24, 2025
  • Artificial Intelligence,Clinical Trials,Drug Development,Technology and platforms

    Accelerating R&D in pharma: Inside Veeva’s mission to cut time-to-patient

    Stephan Ohnmacht, VP of R&D Business Consulting at Veeva Systems, [...]

    June 6, 2025
  • Clinical Trials,Drug Development,Market Access & Commercialization,Precision medicine,Technology and platforms,Uncategorised

    Veeva unveils bold vision for simplifying, standardising, and AI-powered innovation

    In a keynote address that signaled both reflection and momentum, [...]

    June 5, 2025
  • Artificial Intelligence,Clinical Trials,Regulatory Affairs

    Clinical trial innovation hampered by change fatigue and skills gaps, survey finds

    A new survey from eClinical Solutions reveals that biopharma organizations [...]

    May 27, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Clinical Trials,Drug Development

    Lonza launches Design2Optimize platform to accelerate API development

    Lonza has unveiled a new model-based development platform, Design2Optimize, which [...]

    May 23, 2025
  • Artificial Intelligence,Drug Development

    Pharma’s innovation blind spot: Why speed and business model agility will define the next decade

    Pharmaceutical innovation is at a critical inflection point. Most companies [...]

    May 22, 2025
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top